CH547809A - Verfahren zur herstellung von pyrazinderivaten. - Google Patents

Verfahren zur herstellung von pyrazinderivaten.

Info

Publication number
CH547809A
CH547809A CH454470A CH454470A CH547809A CH 547809 A CH547809 A CH 547809A CH 454470 A CH454470 A CH 454470A CH 454470 A CH454470 A CH 454470A CH 547809 A CH547809 A CH 547809A
Authority
CH
Switzerland
Prior art keywords
manufacturing
pyrazine derivatives
pyrazine
derivatives
manufacturing pyrazine
Prior art date
Application number
CH454470A
Other languages
English (en)
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of CH547809A publication Critical patent/CH547809A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH454470A 1969-03-26 1970-03-25 Verfahren zur herstellung von pyrazinderivaten. CH547809A (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1458169 1969-03-26
IT1830169 1969-06-18

Publications (1)

Publication Number Publication Date
CH547809A true CH547809A (de) 1974-04-11

Family

ID=26326731

Family Applications (1)

Application Number Title Priority Date Filing Date
CH454470A CH547809A (de) 1969-03-26 1970-03-25 Verfahren zur herstellung von pyrazinderivaten.

Country Status (14)

Country Link
US (1) US3669966A (de)
BE (1) BE747405A (de)
CA (1) CA952112A (de)
CH (1) CH547809A (de)
CY (1) CY645A (de)
DE (1) DE2012138C3 (de)
DK (1) DK128320B (de)
FI (1) FI52720C (de)
FR (1) FR2035890B1 (de)
GB (1) GB1249443A (de)
IL (1) IL34153A (de)
MY (1) MY7300007A (de)
NL (1) NL138933B (de)
NO (1) NO127399B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3320583A1 (de) * 1983-06-08 1984-12-13 Dr. Karl Thomae Gmbh, 7950 Biberach Neue galenische zubereitungsformen von oralen antidiabetika und verfahren zu ihrer herstellung
DE3320582A1 (de) * 1983-06-08 1984-12-13 Dr. Karl Thomae Gmbh, 7950 Biberach Gliquidonhaltige zubereitungsformen und verfahren zu ihrer herstellung
US5196410A (en) * 1986-10-31 1993-03-23 Pfizer Inc. Transdermal flux enhancing compositions
US6361795B1 (en) 1989-09-05 2002-03-26 Alza Corporation Method for lowering blood glucose
US5516906A (en) * 1995-01-17 1996-05-14 Usv Limited Process for the preparation of N-[2-[4-(aminosulfonyl) phenyl]ethyl]5-methylpyrazinecarboxamide
US8236352B2 (en) * 1998-10-01 2012-08-07 Alkermes Pharma Ireland Limited Glipizide compositions
US7041691B1 (en) * 1999-06-30 2006-05-09 Amgen Inc. Compounds for the modulation of PPARγ activity
WO2001082916A2 (en) * 2000-05-03 2001-11-08 Tularik Inc. Combination therapeutic compositions and methods of use
US20030171399A1 (en) * 2000-06-28 2003-09-11 Tularik Inc. Quinolinyl and benzothiazolyl modulators
US8268352B2 (en) * 2002-08-05 2012-09-18 Torrent Pharmaceuticals Limited Modified release composition for highly soluble drugs
US8216609B2 (en) * 2002-08-05 2012-07-10 Torrent Pharmaceuticals Limited Modified release composition of highly soluble drugs
US7223761B2 (en) * 2003-10-03 2007-05-29 Amgen Inc. Salts and polymorphs of a potent antidiabetic compound
US20070025953A1 (en) * 2005-07-27 2007-02-01 Jones Michael R Co-therapy for diabetic conditions
WO2008121563A2 (en) 2007-03-30 2008-10-09 Ambrx, Inc. Modified fgf-21 polypeptides and their uses
MX2017004947A (es) 2014-10-24 2017-06-29 Bristol Myers Squibb Co Polipeptidos del factor de crecimiento de fibroblastos 2 (fgf-21) modificados y usos de los mismos.
CN105399692A (zh) * 2015-12-18 2016-03-16 四川大学 格列吡嗪晶型iii及其制备方法
WO2018078657A1 (en) * 2016-10-28 2018-05-03 J.B. Chemicals & Pharmaceuticals Limited Process for preparation of glipizide

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1185180B (de) * 1963-10-19 1965-01-14 Hoechst Ag Verfahren zur Herstellung von Benzolsulfonylharnstoffen
NL6707184A (de) * 1966-06-06 1967-12-07
US3573305A (en) * 1968-12-30 1971-03-30 Merck & Co Inc (3-amino-pyrazinoyl)sulfamides and their preparation

Also Published As

Publication number Publication date
NL138933B (nl) 1973-05-15
NO127399B (de) 1973-06-18
DE2012138C3 (de) 1978-08-10
FR2035890A1 (de) 1970-12-24
CY645A (en) 1972-06-16
FI52720B (de) 1977-08-01
GB1249443A (en) 1971-10-13
BE747405A (fr) 1970-08-31
CA952112A (en) 1974-07-30
FI52720C (fi) 1977-11-10
IL34153A (en) 1972-12-29
FR2035890B1 (de) 1974-01-11
DE2012138A1 (de) 1970-10-01
DK128320B (da) 1974-04-08
DE2012138B2 (de) 1977-12-15
IL34153A0 (en) 1970-05-21
US3669966A (en) 1972-06-13
NL6915776A (de) 1970-09-29
MY7300007A (en) 1973-12-31

Similar Documents

Publication Publication Date Title
CH552607A (de) Verfahren zur herstellung von azaspiroalkandion-derivaten.
CH554877A (de) Verfahren zur herstellung von neuen chinazolinon- bzw. chinazolinthionderivaten.
CH557394A (de) Verfahren zur herstellung von hydrogelen.
CH547809A (de) Verfahren zur herstellung von pyrazinderivaten.
CH546805A (de) Verfahren zur herstellung von polyphenylenoxyden.
CH549029A (de) Verfahren zur herstellung von dihydrobenzodiazepinonen.
CH551990A (de) Verfahren zur herstellung von arylsubstituierten piperazinylalkylaminouracilen, -uracilaethern und -uracilthioaethern.
CH547290A (de) Verfahren zur herstellung von nitro-imidazolderivaten.
CH552593A (de) Verfahren zur herstellung von pyridinthioacetamidderivaten.
CH556322A (de) Verfahren zur herstellung von neuen naphthylalkylaminen.
CH558349A (de) Verfahren zur herstellung von furan-3-carboxamiden.
CH557823A (de) Verfahren zur herstellung von piperazinderivaten.
CH557345A (de) Verfahren zur herstellung von tetrahydropyranolen.
CH549010A (de) Verfahren zur herstellung von novenamin.
CH558799A (de) Verfahren zur herstellung von naphthalimidderivaten.
CH552631A (de) Verfahren zur herstellung von n-acylderivaten von phosphoramidothioaten.
CH550166A (de) Verfahren zur herstellung von indolderivaten.
CH555801A (de) Verfahren zur herstellung von phenylaethanolamin-derivaten.
CH547298A (de) Verfahren zur herstellung von pyrimidopyridazinen.
CH548345A (de) Verfahren zur herstellung von vanadinoxitrichlorid.
CH555826A (de) Verfahren zur herstellung von indolderivaten.
CH548979A (de) Verfahren zur herstellung von chalconderivaten.
CH551985A (de) Verfahren zur herstellung von pyrazinderivaten.
CH550817A (de) Verfahren zur herstellung von stilben-derivaten.
CH549572A (de) Verfahren zur herstellung von substituierten dihydronormorphinonen.

Legal Events

Date Code Title Description
PFA Name/firm changed

Owner name: FARMITALIA CARLO ERBA S.R.L.

PL Patent ceased